[go: up one dir, main page]

ID29533A - Senyawa-senyawa kalsilitik - Google Patents

Senyawa-senyawa kalsilitik

Info

Publication number
ID29533A
ID29533A IDW00200101673A ID20011673A ID29533A ID 29533 A ID29533 A ID 29533A ID W00200101673 A IDW00200101673 A ID W00200101673A ID 20011673 A ID20011673 A ID 20011673A ID 29533 A ID29533 A ID 29533A
Authority
ID
Indonesia
Prior art keywords
calsilitic
compounds
calsilitic compounds
Prior art date
Application number
IDW00200101673A
Other languages
English (en)
Inventor
Amparo Maria Lago
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Publication of ID29533A publication Critical patent/ID29533A/id

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/57Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and carboxyl groups, other than cyano groups, bound to the carbon skeleton
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/04Drugs for skeletal disorders for non-specific disorders of the connective tissue
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/18Drugs for disorders of the endocrine system of the parathyroid hormones
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/54Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and etherified hydroxy groups bound to the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00Carboxylic acid nitriles
    • C07C255/49Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C255/56Carboxylic acid nitriles having cyano groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton containing cyano groups and doubly-bound oxygen atoms bound to the carbon skeleton

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Investigating Or Analyzing Non-Biological Materials By The Use Of Chemical Means (AREA)
IDW00200101673A 1999-02-02 2000-02-02 Senyawa-senyawa kalsilitik ID29533A (id)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US11824099P 1999-02-02 1999-02-02

Publications (1)

Publication Number Publication Date
ID29533A true ID29533A (id) 2001-09-06

Family

ID=22377367

Family Applications (1)

Application Number Title Priority Date Filing Date
IDW00200101673A ID29533A (id) 1999-02-02 2000-02-02 Senyawa-senyawa kalsilitik

Country Status (24)

Country Link
US (1) US6417215B1 (id)
EP (1) EP1148876A4 (id)
JP (1) JP2002536330A (id)
KR (1) KR20010093285A (id)
CN (1) CN1346269A (id)
AP (1) AP2001002220A0 (id)
AU (1) AU3480200A (id)
BG (1) BG105847A (id)
BR (1) BR0007922A (id)
CA (1) CA2361589A1 (id)
CO (1) CO5251439A1 (id)
CZ (1) CZ20012797A3 (id)
EA (1) EA200100854A1 (id)
HK (1) HK1042036A1 (id)
HU (1) HUP0200121A3 (id)
ID (1) ID29533A (id)
IL (1) IL144470A0 (id)
MA (1) MA25379A1 (id)
NO (1) NO20013769L (id)
OA (1) OA11757A (id)
PE (1) PE20001456A1 (id)
SK (1) SK10982001A3 (id)
WO (1) WO2000045816A1 (id)
ZA (1) ZA200106298B (id)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100785675B1 (ko) * 2000-08-11 2007-12-14 니뽄 다바코 산교 가부시키가이샤 칼슘 수용체 길항약
ATE343390T1 (de) * 2000-10-25 2006-11-15 Smithkline Beecham Corp Kalzilytische verbindungen
US6864267B2 (en) * 2001-07-16 2005-03-08 Smithkline Beecham Corporation Calcilytic compounds
UY28089A1 (es) * 2002-11-26 2004-06-30 Smithkline Beecham Corp Compuestos calciliticos
WO2004069793A2 (en) 2003-01-28 2004-08-19 Bristol-Myers Squibb Company Novel 2-substituted cyclic amines as calcium sensing receptor modulators
US7205322B2 (en) 2003-02-12 2007-04-17 Bristol-Myers Squibb Company Thiazolidine compounds as calcium sensing receptor modulators
WO2004094362A1 (ja) * 2003-04-23 2004-11-04 Japan Tobacco Inc. CaSRアンタゴニスト
EP1630157A4 (en) * 2003-05-28 2007-05-23 Japan Tobacco Inc ANTAGONIST OF CASR
US7265145B2 (en) 2003-05-28 2007-09-04 Bristol-Myers Squibb Company Substituted piperidines and pyrrolidines as calcium sensing receptor modulators and method
EP1964548A1 (en) * 2007-03-02 2008-09-03 Novartis AG Pharmaceutical compositions comprising a calcilytic agent
DK2292592T3 (da) 2008-06-05 2012-10-08 Asahi Kasei Pharma Corp Sulfonamidforbindelse og anvendelse deraf
WO2010103429A1 (en) 2009-03-10 2010-09-16 Pfizer Inc. 1,1-(Dimethyl-Ethylamino)-2-Hydroxy-Propoxy]-Ethyl}-3-Methyl-Biphenyl-4- Carboxylic Acid Derivatives As Calcium Receptor Antagonists
GB201217330D0 (en) 2012-09-28 2012-11-14 Univ Cardiff Therapeutic for treating inflammatory lung disorders
WO2021029517A1 (en) * 2019-08-13 2021-02-18 Dongguk University Industry-Academic Cooperation Foundation Pharmaceutical composition for improving or treating post-surgical hypoparathyroidism and treatment method using the same

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE122007000050I1 (de) * 1990-02-19 2007-11-08 Novartis Ag Acylverbindungen
DE4102024A1 (de) * 1991-01-24 1992-07-30 Thomae Gmbh Dr K Biphenylderivate, diese verbindungen enthaltende arzneimittel und verfahren zu ihrer herstellung
BR9708632A (pt) * 1996-04-09 2000-01-18 Nps Pharma Inc Composto calcilìticos
UY24949A1 (es) * 1997-04-08 2001-04-30 Smithkline Beecham Corp Compuestos calcilíticos

Also Published As

Publication number Publication date
AP2001002220A0 (en) 2001-09-30
HK1042036A1 (zh) 2002-08-02
EP1148876A1 (en) 2001-10-31
JP2002536330A (ja) 2002-10-29
HUP0200121A2 (hu) 2002-05-29
US6417215B1 (en) 2002-07-09
NO20013769L (no) 2001-09-26
CN1346269A (zh) 2002-04-24
CZ20012797A3 (cs) 2002-01-16
EA200100854A1 (ru) 2002-02-28
HUP0200121A3 (en) 2002-11-28
KR20010093285A (ko) 2001-10-27
ZA200106298B (en) 2002-10-18
IL144470A0 (en) 2002-05-23
PE20001456A1 (es) 2001-01-28
NO20013769D0 (no) 2001-08-01
CA2361589A1 (en) 2000-08-10
MA25379A1 (fr) 2002-04-01
BR0007922A (pt) 2001-11-06
CO5251439A1 (es) 2003-02-28
BG105847A (en) 2002-04-30
AU3480200A (en) 2000-08-25
SK10982001A3 (sk) 2001-12-03
OA11757A (en) 2005-07-19
EP1148876A4 (en) 2003-07-23
WO2000045816A1 (en) 2000-08-10

Similar Documents

Publication Publication Date Title
EE200100502A (et) Ühendid
IS6239A (is) Ný efnasambönd
NO20016115L (no) Substituerte heterosykelkondenserte gamma-karbolin
PT1224180E (pt) Azois substituidos
ATA51899A (de) Handstempel
EE200200224A (et) Uudsed ühendid
IS6139A (is) Ný efnasambönd
DE60045545D1 (de) Klebefolie
ID29533A (id) Senyawa-senyawa kalsilitik
NO20020773D0 (no) Borkronekobling
DE50000805D1 (de) Aufsitzspanner
NO20020466L (no) Kalsilytiske forbindelser
IS6141A (is) Ný efnasambönd
NO20014262D0 (no) Tiazoloindolinon-forbindelser
NO20022927D0 (no) Substituerte pyrrazoler
ATA121799A (de) Ausbeulgerät
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
DK1200423T3 (da) Substituerede pehnyluraciler
ATA732000A (de) Kachelofen
AT500658A3 (de) Isolierplatte
SE9900086D0 (sv) New compounds
SE9904418D0 (sv) New compounds
SE9904422D0 (sv) New compounds
SE9904420D0 (sv) New compounds
SE9904228D0 (sv) New compounds